Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Aclaris Therapeutics (ACRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
16 analysts
Options Flow (P/C)
0.68
More calls — Bullish
Avg Consensus PT
$10
+182.4%
Highest Price Target
$16
+362.4%
Lowest Price Target
$1
-71.1%
Short Interest
12.4%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Canaccord Genuity | Edward Nash— | +189.0% | $10 | Initiate | Buy |
| Jun 2, 2026 | LifeSci Capital | —— | +275.7% | $13 | Initiate | Outperform |